BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT07105059 updates: 1. allocation: NA → RANDOMIZED 2. intervention model: SINGLE_GROUP → SEQUENTIAL
Clinical trial NCT07105059 updates: 1. allocation: NA → RANDOMIZED 2. intervention model: SINGLE_GROUP → SEQUENTIAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical